Internal Medicine, Infectious Disease · Overland Park, KS
NPI
1689752909
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
0
Medicare group memberships
Hospitals
3
Hospital affiliations
7011 W 121st St
Overland Park, KS, 66209
Phone (913) 884-1055
Medicare paid, 2024
$33K
612 services
Medicare patients, 2024
81
Average age 74
Drug cost, 2024
$727K
703 prescriptions
Company payments, 2025
$822
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John S Fried was code 11042 (debridement), 191 times for 34 patients. In total John S Fried billed 612 services in 13 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 11042 Debridement | Facility | 191 | 34 | $43.94 | $8,393 |
| 99213 Office E&M - Established | Facility | 81 | 23 | $48.47 | $3,926 |
| 99212 Office E&M - Established | Facility | 80 | 19 | $25.58 | $2,047 |
| 99213 Office E&M - Established | Office | 63 | 24 | $60.39 | $3,804 |
| 99214 Office E&M - Established | Office | 46 | 18 | $88.06 | $4,051 |
| 99214 Office E&M - Established | Facility | 32 | 16 | $71.60 | $2,291 |
| 99203 Office E&M - New | Facility | 12 | 12 | $60.08 | $721 |
By year: 2022 $29K for 459 services; 2023 $30K for 587 services; 2024 $33K for 612 services.
Medicare prescription drug claims, 2024
In 2024, the drug John S Fried prescribed most often to Medicare patients was Dovato (Dolutegravir Sodium/Lamivudine), with 38 prescriptions and refills. In total John S Fried wrote 703 Medicare prescriptions that cost $727K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dovato Dolutegravir Sodium/Lamivudine | 38 | 38 | Under 11 | $112K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 36 | 36 | Under 11 | $136K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 34 | 34 | Under 11 | $140K |
| Amoxicillin Generic | 29 | 57 | Under 11 | $135 |
| Prezcobix Darunavir/Cobicistat | 26 | 26 | Under 11 | $73K |
| Doxycycline Hyclate Generic | 25 | 25 | Under 11 | $413 |
| Ciprofloxacin Hcl Generic | 24 | 24 | Under 11 | $556 |
| Mupirocin Generic | 24 | 24 | 12 | $105 |
| Cefadroxil Generic | 23 | 31 | Under 11 | $944 |
| Trazodone Hcl Generic | 17 | 17 | Under 11 | $15.78 |
| Ceftriaxone Ceftriaxone Sodium | 16 | 16 | Under 11 | $535 |
| Ssd Silver Sulfadiazine | 15 | 17 | Under 11 | $293 |
| Santyl Collagenase Clostridium Hist. | 14 | 15 | Under 11 | $28K |
| Losartan Potassium Generic | 14 | 35 | Under 11 | $66.97 |
| Quetiapine Fumarate Generic | 13 | 15 | Under 11 | $0.65 |
Brand drugs: - claims; generic drugs: 436 claims; opioid claims: 33.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John S Fried $822 ($822 in general payments such as food, travel and fees) from 15 companies. The largest payer was Gilead Sciences, Inc. with $200.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 7 | $200 |
| Merck Sharp & Dohme LLC MRK | 6 | $156 |
| Integra LifeSciences Corporation IART | 1 | $82.83 |
| ViiV Healthcare Company GSK | 3 | $68.04 |
| Abbvie Inc. ABBV | 3 | $64.56 |
| Insmed, Inc. INSM | 2 | $39.28 |
| Melinta Therapeutics, LLC | 2 | $38.7 |
| ConvaTec Inc. CTEC.L | 2 | $34.26 |
| Smith+Nephew, Inc. SNN | 1 | $27.8 |
| Organogenesis Inc. ORGO | 1 | $20.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.